Replies to post #374257 on Amarin Corp Plc (AMRN)

[mrmainstreet]

Holy Shit

[hayward]

rafunrafun

What in the world are 300 sales people doing !!! Unbelievable !


Michael

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[rosemountbomber]

Thanks Raf. Well last week’s numbers that caused us to think better times were ahead have been negated again.

[Megc]

Thanks Raf for the scripts

[rafunrafun]

Scripts for week ending April 1, 2022

Drug Industry TRx: +1.6% w/w; +10.4% y/y

Vascepa
TRx 69,690; -0.4% (-296) w/w; -15.3% y/y
NRx 31,954; -1.5% (-478) w/w; -15.2% y/y
Ref 37,736; +0.5% (+182) w/w; -15.5% y/y

Lovaza (Generic & Brand)
TRx 62,591; +1.4% (+873) w/w; +2.3% y/y
NRx 32,589; -0.2% (-62) w/w; +6.2% y/y
Ref 30,064; +3.2% (+945) w/w; -1.6% y/y

Generic Vascepa
TRx 30,636; +0.5% (+144) w/w; As % of total V: 30.5%
NRx 16,618; -0.4% (-67) w/w; As % of total V: 34.2%
Ref 14,019; +1.5% (+211) w/w; As % of total V: 27.1%

Generic Vascepa by Manufacturer
Hikma - TRx 7,462; (+202) w/w; Generic share 24.4%; Total V share 7.4%
Reddy - TRx 13,511; (-356) w/w; Generic share 44.1%; Total V share 13.5%
Apotex - TRx 9,664; (+299) w/w; Generic share 31.5%; Total V share 9.6%

Vascepa + Generic Vascepa
TRx 100,327; -0.2% (-152) w/w; +11.0% y/y
NRx 48,572; -1.1% (-545) w/w; +15.2% y/y
Ref 51,755; +0.8% (+393) w/w; +7.3% y/y